TP53 and acute kidney injury: Due to the distinct advantages of low immunogenicity, biocompatibility, biological barrier permeability, and stability 14,47,54, MSC-exos carrying naturally loaded miR-125b-5p may represent a superior therapeutic strategy of repressing p53 signaling for tubular repair in AKI.